SUN PHARMA LABORATORIES LIMITED vs ZAWADI HEALTHCARE LIMITED — HCBM20046112023

Case under Trade & Trade Merchandise Marks Act Section 87. Next hearing: 01st April 2026.

Next hearing 01-Apr-2026

CNR: HCBM020046112023

e-Filing Number

15-02-2023

Filing Number

IA/4610/2023

Filing Date

16-Feb-2023

Judge

Hon'ble Justice Sharmila U. Deshmukh

Coram

Hon'ble Justice Sharmila U. Deshmukh

Bench Type

Single

Judicial Branch

Original

Last updated 05-May-2026

Acts & Sections

Trade & Trade Merchandise Marks Act Section 87

Petitioner(s)

  1. 1.SUN PHARMA LABORATORIES LIMITED

    Adv. Legasis Partners

Respondent(s)

  1. 1.ZAWADI HEALTHCARE LIMITED

  2. 2.SYNCOM FORMULATIONS INDIA LIMITED

Case History

  1. 01-Apr-2026

    Next hearingPending

  2. 01-Apr-2026

    Hon'ble Justice Sharmila U. DeshmukhView PDF

    Summary The Bombay High Court granted an interim injunction in favor of Sun Pharma Laboratories Limited against Zawadi Healthcare Limited for trademark infringement. The court found that the defendant's mark "PANTOZED-40" is deceptively similar to the plaintiff's registered trademark "PANTOCID" (both derived from the drug molecule PANTOPRAZOLE), noting phonetic similarity between the suffixes "CID" and "ZED," and established prior use by the plaintiff since 1998. However, the court denied interim relief on the passing-off claim, finding insufficient evidence of misrepresentation affecting the plaintiff's Indian market. This case analysis is maintained by casestatus.in based on publicly available court records.

  3. 12-Mar-2026

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  4. 12-Mar-2026

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  5. 03-Feb-2026

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  6. 03-Feb-2026

    Due Matters - Adjourned OS

    Hon'ble Justice Sharmila U. Deshmukh

  7. 07-Jan-2026

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  8. 07-Jan-2026

    For Circulation

    Hon'ble Justice Sharmila U. Deshmukh

  9. 19-Dec-2025

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  10. 19-Dec-2025

    For Circulation

    Hon'ble Justice Sharmila U. Deshmukh

  11. 05-Dec-2025

    Hon'ble Justice Sharmila U. DeshmukhView PDF

  12. 04-Feb-2025

    Hon'ble Shri Justice Manish PitaleView PDF

  13. 11-Mar-2024

    For Circulation

    Hon'ble Smt. Justice Bharati Dangre

  14. 06-Feb-2024

    Hon'ble Smt. Justice Bharati DangreView PDF

  15. 08-Dec-2023

    Interim Application

    Hon'ble Shri Justice R. I. Chagla

  16. 17-Oct-2023

    Hon'ble Shri Justice R. I. ChaglaView PDF

  17. 17-Oct-2023

    For Extension Of Time

    Hon'ble Shri Justice R. I. Chagla

  18. 26-Sep-2023

    Hon'ble Shri Justice R. I. ChaglaView PDF

  19. 21-Sep-2023

    For Ad-Interim Relief

    Hon'ble Shri Justice R. I. Chagla

  20. 11-Aug-2023

    Hon'ble Shri Justice R. I. ChaglaView PDF

  21. 11-Aug-2023

    For Ad-Interim Relief

    Hon'ble Shri Justice R. I. Chagla

  22. 13-Jul-2023

    Hon'ble Shri Justice R. I. ChaglaView PDF

  23. 13-Jul-2023

    For Ad-Interim Relief

    Hon'ble Shri Justice R. I. Chagla

  24. 19-Jun-2023

    Hon'ble Shri Justice R. I. ChaglaView PDF

  25. 19-Jun-2023

    For Ad-Interim Relief

    Hon'ble Shri Justice Manish Pitale

  26. 17-Apr-2023

    Hon'ble Shri Justice Manish PitaleView PDF

  27. 17-Apr-2023

    For Ad-Interim Relief

    Hon'ble Shri Justice Manish Pitale

  28. 17-Mar-2023

    Hon'ble Shri Justice Manish PitaleView PDF

  29. 03-Mar-2023

    Hon'ble Shri Justice Manish PitaleView PDF

  30. 03-Mar-2023

    For Ad-Interim Relief

    Hon'ble Shri Justice Manish Pitale

  31. 24-Feb-2023

    Hon'ble Shri Justice Manish PitaleView PDF

  32. 24-Feb-2023

    First hearing

    Initial hearing scheduled

  33. 16-Feb-2023

    Case filed

casestatus.in Summary

Summary The Bombay High Court granted an interim injunction in favor of Sun Pharma Laboratories Limited against Zawadi Healthcare Limited for trademark infringement. The court found that the defendant's mark "PANTOZED-40" is deceptively similar to the plaintiff's registered trademark "PANTOCID" (both derived from the drug molecule PANTOPRAZOLE), noting phonetic similarity between the suffixes "CID" and "ZED," and established prior use by the plaintiff since 1998. However, the court denied interim relief on the passing-off claim, finding insufficient evidence of misrepresentation affecting the plaintiff's Indian market. This case analysis is maintained by casestatus.in based on publicly available court records.

Explore other courts

Search Another Case